- Home
- BRAG vs ALLK Comparison
BRAG vs ALLK Comparison
Compare BRAG & ALLK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BRAG
- ALLK
- Stock Information
- Founded
- BRAG 2018
- ALLK 2012
- Country
- BRAG Canada
- ALLK United States
- Employees
- BRAG N/A
- ALLK N/A
- Industry
- BRAG Office Equipment/Supplies/Services
- ALLK Biotechnology: Pharmaceutical Preparations
- Sector
- BRAG Technology
- ALLK Health Care
- Exchange
- BRAG Nasdaq
- ALLK Nasdaq
- Market Cap
- BRAG 114.3M
- ALLK 101.0M
- IPO Year
- BRAG N/A
- ALLK 2018
- Fundamental
- Price
- BRAG $3.31
- ALLK $0.88
- Analyst Decision
- BRAG Buy
- ALLK Hold
- Analyst Count
- BRAG 2
- ALLK 5
- Target Price
- BRAG $7.50
- ALLK $1.67
- AVG Volume (30 Days)
- BRAG 81.6K
- ALLK 652.1K
- Earning Date
- BRAG 11-14-2024
- ALLK 11-06-2024
- Dividend Yield
- BRAG N/A
- ALLK N/A
- EPS Growth
- BRAG N/A
- ALLK N/A
- EPS
- BRAG N/A
- ALLK N/A
- Revenue
- BRAG $109,522,641.00
- ALLK N/A
- Revenue This Year
- BRAG $10.73
- ALLK N/A
- Revenue Next Year
- BRAG $9.35
- ALLK N/A
- P/E Ratio
- BRAG N/A
- ALLK N/A
- Revenue Growth
- BRAG 4.64
- ALLK N/A
- 52 Week Low
- BRAG $2.86
- ALLK $0.54
- 52 Week High
- BRAG $7.00
- ALLK $3.41
- Technical
- Relative Strength Index (RSI)
- BRAG 27.29
- ALLK 38.32
- Support Level
- BRAG $3.20
- ALLK $1.29
- Resistance Level
- BRAG $3.41
- ALLK $1.56
- Average True Range (ATR)
- BRAG 0.22
- ALLK 0.13
- MACD
- BRAG -0.09
- ALLK -0.07
- Stochastic Oscillator
- BRAG 25.86
- ALLK 10.53
About BRAG Bragg Gaming Group Inc.
Bragg Gaming Group Inc is predominantly a B2B online gaming technology platform and casino content aggregator. The Company's proprietary studios offer high-performing, data-driven casino gaming titles from in-house brands Wild Streak, Spin, Atomic Slot Lab, Indigo Magic and Oryx Gaming. It offers a full range of games including slot games, table games, card games, video bingo, scratch card games, virtual sports, and live dealer games which are featured on the company's PAM platform and also available for use on other gaming platforms offered by third parties. Geographically, the company generates a majority of its revenue from the Netherlands and the rest from Curacao, Malta, United States, Croatia, and other regions.
About ALLK Allakos Inc.
Allakos Inc is a clinical-stage company developing therapeutic antibodies that selectively target immunomodulatory receptors present on the surface of immune effector cells involved in allergic, inflammatory, and proliferative diseases. The company's lead program, AK006 targets Siglec-6, an inhibitory receptor expressed selectively on mast cells. Binding of AK006 to Siglec-6 is designed to activate the native inhibitory function of the receptor which in turn reduces mast cell activation.